Skip to main content
. Author manuscript; available in PMC: 2014 Sep 2.
Published in final edited form as: Lancet. 2011 Sep 9;378(9802):1547–1559. doi: 10.1016/S0140-6736(11)61383-4

Table 5.

Absolute and percent change from baseline in PET/CT measurements of inflammation after 3 and 6 months (average of carotid arteries)

Absolute values, mean (SE) Least squares mean (SE) absolute or percent change from baseline Absolute change from baseline relative to placebo (90% CI) p value*


Placebo Dalcetrapib Placebo Dalcetrapib
Most diseased segment mean of maximumTBRabsolutechange

Baseline 1·81 (0·08) 2·09 (0·09) ·· ·· ·· ··
Month 3 1·86 (0·06) 1·97 (0·07) −0·02 (0·06) −0·11 (0·06) −0·09 (−0·23 to 0·05) 0·31
Month 6 1·82 (0·05) 1·89 (0·06) −0·04 (0·06) −0·19 (0·06) −0·15 (−0·29 to −0·01 0·08

Most diseased segment mean of maximumTBRpercent change
Month 3 ·· ·· −0·5 −4·4 −4·0 (−10·4 to 2·9 0·33
Month 6 ·· ·· −1·1 −8·4 −7·3 (−13·5 to − 0·8) 0·07

SE=standard error. TBR=target to background ratio.

*

p-values (2-sided) are presented for the difference between groups.

n=24 for placebo and n=27 for dalcetrapib at baseline and month 6, and n=24 for placebo and n=26 for dalcetrapib at month 3.